>
pdufa.bio

elebsiran

Updated ยทnext FDA decision on the calendar

elebsiran is a Alnylam Pharmaceuticals, Inc. program. Its next catalyst is a Readout in Q4 2026. Every date links its source.

ALNY catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Alnylam Pharmaceuticals, Inc. (ALNY). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Q4 2026ALNY

Questions

When is elebsiran's next FDA decision or readout?

The next tracked catalyst for elebsiran is a Readout in Q4 2026.

What happened at elebsiran's most recent FDA decision?

No FDA decision for elebsiran is in our archive yet.

Who makes elebsiran?

Alnylam Pharmaceuticals, Inc. (ALNY).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.